标题
Selected cytokine pathways in rheumatoid arthritis
作者
关键词
Rheumatoid arthritis, Pro-inflammatory cytokine pathway, Biotherapies
出版物
Seminars in Immunopathology
Volume 39, Issue 4, Pages 365-383
出版商
Springer Nature
发表日期
2017-02-17
DOI
10.1007/s00281-017-0619-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
- (2018) Jonas Bystrom et al. CYTOKINE
- Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis
- (2016) Ndieme Ndongo-Thiam et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti cytokine therapy in chronic inflammatory arthritis
- (2016) Charlotte Thompson et al. CYTOKINE
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- Secukinumab for rheumatology: development and its potential place in therapy
- (2016) Marije Koenders et al. Drug Design Development and Therapy
- Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
- (2016) Pietro Enea Lazzerini et al. Drug Design Development and Therapy
- A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis
- (2015) Ndiémé Ndongo-Thiam et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms
- (2015) S Ajeganova et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
- (2015) Maciej Tarnowski et al. Expert Opinion on Drug Metabolism & Toxicology
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
- (2015) Aoi Shiomi et al. MEDIATORS OF INFLAMMATION
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Targeting GM-CSF in inflammatory diseases
- (2015) Ian P. Wicks et al. Nature Reviews Rheumatology
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Cytokines in rheumatoid arthritis — shaping the immunological landscape
- (2015) Iain B. McInnes et al. Nature Reviews Rheumatology
- Interleukin-1 function and role in rheumatic disease
- (2015) Georg Schett et al. Nature Reviews Rheumatology
- TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
- (2015) L. Probert NEUROSCIENCE
- Association ofHLA-DRB1alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis
- (2015) Gerd R. Burmester et al. RHEUMATOLOGY
- Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis
- (2015) Annemarie E. M. van Nieuwenhuijze et al. ARTHRITIS RESEARCH & THERAPY
- Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
- (2015) György Nagy et al. ARTHRITIS RESEARCH & THERAPY
- The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra
- (2015) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study
- (2015) Mark C. Genovese et al. Arthritis & Rheumatology
- MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- (2014) Frank Behrens et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
- (2014) Sofia Ramiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
- (2014) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab
- (2014) Yoshiya Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- GM-CSF but Not IL-17 Is Critical for the Development of Severe Interstitial Lung Disease in SKG Mice
- (2014) Aoi Shiomi et al. JOURNAL OF IMMUNOLOGY
- Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
- (2014) I. L. Campbell et al. JOURNAL OF NEUROSCIENCE
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels
- (2014) Pia Isomäki et al. RHEUMATOLOGY
- Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
- (2014) Glynn Dennis et al. ARTHRITIS RESEARCH & THERAPY
- The disease formerly known as rheumatoid arthritis
- (2014) Gary S Firestein ARTHRITIS RESEARCH & THERAPY
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- (2013) Tom W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor Necrosis Factor α Induces Sustained Signaling and a Prolonged and Unremitting Inflammatory Response in Rheumatoid Arthritis Synovial Fibroblasts
- (2013) Angela Lee et al. ARTHRITIS AND RHEUMATISM
- Signalling by the βc family of cytokines
- (2013) Timothy R. Hercus et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting Interleukin-6 in Rheumatoid Arthritis
- (2013) Md Yuzaiful Md Yusof et al. DRUGS
- Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis
- (2013) Giulia Benedetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- The Role of IL-1 in the Early Tumor Cell-Induced Angiogenic Response
- (2013) Y. Carmi et al. JOURNAL OF IMMUNOLOGY
- GM-CSF as a therapeutic target in inflammatory diseases
- (2013) Annemarie van Nieuwenhuijze et al. MOLECULAR IMMUNOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- The problem of choice: current biologic agents and future prospects in RA
- (2013) Ernest H. Choy et al. Nature Reviews Rheumatology
- SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor
- (2013) Severa Bunda et al. PLoS One
- Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis
- (2013) J. Callhoff et al. RHEUMATOLOGY
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
- (2013) Loris R. Lopetuso et al. Frontiers in Immunology
- TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine
- (2013) Denise L. Faustman et al. Frontiers in Immunology
- IL-17 and tumour necrosis factor α combination induces a HIF-1α-dependent invasive phenotype in synoviocytes
- (2012) Arnaud Hot et al. ANNALS OF THE RHEUMATIC DISEASES
- Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain
- (2012) Andrew D Cook et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
- (2012) P Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and autoimmunity during anti-TNF therapy
- (2012) F. Atzeni et al. AUTOIMMUNITY REVIEWS
- IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
- (2012) J. Hoge et al. JOURNAL OF IMMUNOLOGY
- Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection
- (2012) David B. Chou et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development
- (2012) Andrew D Cook et al. ARTHRITIS RESEARCH & THERAPY
- Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor- , in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
- (2011) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA
- (2011) Siham Ali Metawi et al. CLINICAL RHEUMATOLOGY
- Recent advances in the IL-17 cytokine family
- (2011) Sarah L Gaffen CURRENT OPINION IN IMMUNOLOGY
- Functional Specialization of Interleukin-17 Family Members
- (2011) Yoichiro Iwakura et al. IMMUNITY
- Tocilizumab: is there life beyond anti-TNF blockade?
- (2011) J. D. Alves et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- The Src-Like Adaptor Protein Regulates GM-CSFR Signaling and Monocytic Dendritic Cell Maturation
- (2011) L. M. Liontos et al. JOURNAL OF IMMUNOLOGY
- Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
- (2011) Andreas Hess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Granulocyte/Macrophage Colony–Stimulating Factor Causes a Paradoxical Increase in the BH3-Only Pro-Apoptotic Protein Bim in Human Neutrophils
- (2010) Andrew S. Cowburn et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12R 2 inhibition
- (2010) M.-L. Toh et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression
- (2010) Miho Suzuki et al. CYTOKINE
- Loss of CD4 + T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells
- (2010) Gareth W. Jones et al. JOURNAL OF IMMUNOLOGY
- Hematopoietic colony-stimulating factors: new players in tumor–nerve interactions
- (2010) Sebastian Stösser et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
- Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression
- (2010) Myew-Ling Toh et al. PLoS One
- Differential release of chromatin-bound IL-1 discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation
- (2010) I. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Predictors for remission in rheumatoid arthritis patients: A systematic review
- (2010) Wanruchada Katchamart et al. ARTHRITIS CARE & RESEARCH
- IL-1β Processing in Host Defense: Beyond the Inflammasomes
- (2010) Mihai G. Netea et al. PLoS Pathogens
- The role of IL-1 in the pathogenesis of heart disease
- (2009) Marcin Bujak et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- (2009) Merete Lund Hetland et al. ARTHRITIS AND RHEUMATISM
- Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
- (2009) I. L. King et al. BLOOD
- The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease
- (2009) T. R. Hercus et al. BLOOD
- Animal models of rheumatoid arthritis
- (2009) Darren L. Asquith et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
- (2009) W. A. Neveu et al. JOURNAL OF IMMUNOLOGY
- GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling
- (2009) Andrew J. Fleetwood et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain
- (2009) Matthias Schweizerhof et al. NATURE MEDICINE
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
- (2009) Miho Suzuki et al. RHEUMATOLOGY INTERNATIONAL
- Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
- (2009) C. Liu et al. Science Signaling
- Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor -independent mouse model
- (2008) C Plater-Zyberk et al. ANNALS OF THE RHEUMATIC DISEASES
- Translating Molecular Insights in Autoimmunity into Effective Therapy
- (2008) Marc Feldmann Annual Review of Immunology
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis
- (2008) Yasushi Uchiyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Hematopoietic cytokines
- (2008) D. Metcalf BLOOD
- The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
- (2008) Guido Hansen et al. CELL
- Illuminating the Black Box of TNF Action in Tuberculous Granulomas
- (2008) Elizabeth A. Miller et al. IMMUNITY
- Evidence that cytokines play a role in rheumatoid arthritis
- (2008) Fionula M. Brennan et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
- (2008) Robert S Wallis LANCET INFECTIOUS DISEASES
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search